Generation Bio Co Stock Performance
| GBIO Stock | USD 5.34 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Generation Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Generation Bio is expected to be smaller as well. Generation Bio right now retains a risk of 1.9%. Please check out Generation Bio potential upside, and the relationship between the sortino ratio and skewness , to decide if Generation Bio will be following its current trending patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Generation Bio Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Generation Bio is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
Year To Date Return (2.02) | Ten Year Return (97.84) | All Time Return (97.84) |
| Begin Period Cash Flow | 72.2 M | |
| Total Cashflows From Investing Activities | 94.5 M |
Generation | Build AI portfolio with Generation Stock |
Generation Bio Relative Risk vs. Return Landscape
If you would invest 533.00 in Generation Bio Co on November 27, 2025 and sell it today you would earn a total of 1.00 from holding Generation Bio Co or generate 0.19% return on investment over 90 days. Generation Bio Co is currently generating 0.0216% in daily expected returns and assumes 1.898% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Generation, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Generation Bio Target Price Odds to finish over Current Price
The tendency of Generation Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.34 | 90 days | 5.34 | about 69.15 |
Based on a normal probability distribution, the odds of Generation Bio to move above the current price in 90 days from now is about 69.15 (This Generation Bio Co probability density function shows the probability of Generation Stock to fall within a particular range of prices over 90 days) .
Generation Bio Price Density |
| Price |
Predictive Modules for Generation Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Generation Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Generation Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Generation Bio is not an exception. The market had few large corrections towards the Generation Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Generation Bio Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Generation Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.01 |
Generation Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Generation Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Generation Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Generation Bio is not yet fully synchronised with the market data | |
| Generation Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.89 M. Net Loss for the year was (131.67 M) with loss before overhead, payroll, taxes, and interest of (32.4 M). | |
| Generation Bio Co currently holds about 301.17 M in cash with (88.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07. | |
| Generation Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 66.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 6000 shares by Appelhans Dannielle of Generation Bio at 33.2 subject to Rule 16b-3 |
Generation Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Generation Stock often depends not only on the future outlook of the current and potential Generation Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Generation Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Cash And Short Term Investments | 185.2 M |
Generation Bio Fundamentals Growth
Generation Stock prices reflect investors' perceptions of the future prospects and financial health of Generation Bio, and Generation Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Generation Stock performance.
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (20.20) % | ||||
| Current Valuation | (27.54 M) | ||||
| Shares Outstanding | 6.74 M | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 2.36 X | ||||
| Revenue | 19.89 M | ||||
| Gross Profit | (32.4 M) | ||||
| EBITDA | (74.26 M) | ||||
| Net Income | (131.67 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 93.56 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 7.51 X | ||||
| Cash Flow From Operations | (88.56 M) | ||||
| Earnings Per Share | (9.37) X | ||||
| Market Capitalization | 35.98 M | ||||
| Total Asset | 231.2 M | ||||
| Retained Earnings | (703.04 M) | ||||
| Working Capital | 157.85 M | ||||
About Generation Bio Performance
By examining Generation Bio's fundamental ratios, stakeholders can obtain critical insights into Generation Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Generation Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.51) | (0.54) | |
| Return On Capital Employed | (0.65) | (0.69) | |
| Return On Assets | (0.51) | (0.54) | |
| Return On Equity | (1.76) | (1.67) |
Things to note about Generation Bio performance evaluation
Checking the ongoing alerts about Generation Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Generation Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Generation Bio is not yet fully synchronised with the market data | |
| Generation Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.89 M. Net Loss for the year was (131.67 M) with loss before overhead, payroll, taxes, and interest of (32.4 M). | |
| Generation Bio Co currently holds about 301.17 M in cash with (88.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07. | |
| Generation Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 66.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 6000 shares by Appelhans Dannielle of Generation Bio at 33.2 subject to Rule 16b-3 |
- Analyzing Generation Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Generation Bio's stock is overvalued or undervalued compared to its peers.
- Examining Generation Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Generation Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Generation Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Generation Bio's stock. These opinions can provide insight into Generation Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Biotechnology sector continue expanding? Could Generation diversify its offerings? Factors like these will boost the valuation of Generation Bio. Market participants price Generation higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Generation Bio data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (9.37) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
Generation Bio's market price often diverges from its book value, the accounting figure shown on Generation's balance sheet. Smart investors calculate Generation Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Generation Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.